33 related articles for article (PubMed ID: 28110264)
1. Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma.
Monga J; Pandit S; Chauhan RS; Chauhan CS; Chauhan SS; Sharma M
PLoS One; 2013; 8(7):e68710. PubMed ID: 23894334
[TBL] [Abstract][Full Text] [Related]
2. The Small Glutathione Peroxidase Mimic 5P May Represent a New Strategy for the Treatment of Liver Cancer.
Yin J; Wang B; Zhu X; Qu X; Huang Y; Lv S; Mu Y; Luo G
Molecules; 2017 Sep; 22(9):. PubMed ID: 28885589
[TBL] [Abstract][Full Text] [Related]
3. Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells.
Yang CY; Hsieh CC; Lin CK; Lin CS; Peng B; Lin GJ; Sytwu HK; Chang WL; Chen YW
BMC Complement Altern Med; 2017 Dec; 17(1):555. PubMed ID: 29284481
[TBL] [Abstract][Full Text] [Related]
4. The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma.
Liu Q; Hua S; Wang X; Chen F; Gou S
Cancer Immunol Immunother; 2021 Feb; 70(2):497-508. PubMed ID: 32840656
[TBL] [Abstract][Full Text] [Related]
5. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
6. New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
Tan JL; Li F; Yeo JZ; Yong KJ; Bassal MA; Ng GH; Lee MY; Leong CY; Tan HK; Wu CS; Liu BH; Chan TH; Tan ZH; Chan YS; Wang S; Lim ZH; Toh TB; Hooi L; Low KN; Ma S; Kong NR; Stein AJ; Wu Y; Thangavelu MT; Suzuki A; Periyasamy G; Asara JM; Dan YY; Bonney GK; Chow EK; Lu GD; Ng HH; Kanagasundaram Y; Ng SB; Tam WL; Tenen DG; Chai L
Gastroenterology; 2019 Dec; 157(6):1615-1629.e17. PubMed ID: 31446059
[TBL] [Abstract][Full Text] [Related]
7. Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown.
Wu LZ; Zou Y; Wang BR; Ni HF; Kong YG; Hua QQ; Chen SM
J Transl Med; 2023 Nov; 21(1):792. PubMed ID: 37940975
[TBL] [Abstract][Full Text] [Related]
8. Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma.
Lai HC; Lin HJ; Jeng LB; Huang ST
World J Gastrointest Oncol; 2023 Jan; 15(1):19-35. PubMed ID: 36684056
[TBL] [Abstract][Full Text] [Related]
9. The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation.
Huynh DL; Chandimali N; Zhang JJ; Kim N; Park YH; Kwon T; Jeong DK
Evid Based Complement Alternat Med; 2018; 2018():3909434. PubMed ID: 30154906
[TBL] [Abstract][Full Text] [Related]
10. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.
Hu B; An HM; Wang SS; Chen JJ; Xu L
Molecules; 2016 Jan; 21(2):142. PubMed ID: 26828466
[TBL] [Abstract][Full Text] [Related]
11. Novel patient-derived preclinical models of liver cancer.
Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
[TBL] [Abstract][Full Text] [Related]
12. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines.
Gera M; Kim N; Ghosh M; Sharma N; Huynh DL; Chandimali N; Koh H; Zhang JJ; Kang TY; Park YH; Kwon T; Jeong DK
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():166-176. PubMed ID: 30678901
[TBL] [Abstract][Full Text] [Related]
14. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
[TBL] [Abstract][Full Text] [Related]
15. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
